SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Attack II - A Complete Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Chris who wrote (28595)1/29/2002 10:40:37 AM
From: Paul Shread  Read Replies (1) | Respond to of 52237
 
08:16 ET Merck could eye acquisitions with cash (MRK) 57.00: -- Update -- Hearing talk that Merck's plans to spin off Merck-Medco (see 7:36 comment) could free up cash for acquisitions; one potential target mentioned in the past has been Schering-Plough (SGP 33.20).

SGP looks pretty attractive at these levels; the whole drug sector is trading at a 35-year low relative to the S&P.